These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 6299092)

  • 1. Platelets and malignancy. Rationale and experimental design for the VA Cooperative Study of RA-233 in the treatment of cancer.
    Zacharski LR; Rickles FR; Henderson WG; Martin JF; Forman WB; Van Eeckhout JP; Cornell CJ; Forcier RJ
    Am J Clin Oncol; 1982 Dec; 5(6):593-609. PubMed ID: 6299092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mopidamol on survival in carcinoma of the lung and colon: final report of Veterans Administration Cooperative Study No. 188.
    Zacharski LR; Moritz TE; Baczek LA; Rickles FR; Edwards RL; Forman WB; Forcier RJ; Cornell CJ; Haakenson CM; Ballard HS
    J Natl Cancer Inst; 1988 Mar; 80(2):90-7. PubMed ID: 2830407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemotherapy plus RA233 in the treatment of oat cell lung cancer.
    Lipton A; Harvey HA; Walker B; Dixon R; Valdivia D; Barnes S; Gordon R; White-Hershey D; Bartholomew MJ; Warzawski N
    Am J Clin Oncol; 1989 Jun; 12(3):259-63. PubMed ID: 2543207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and experimental design for the VA Cooperative Study of Anticoagulation (Warfarin) in the Treatment of Cancer.
    Zacharski LR; Henderson WG; Rickles FR; Forman WB; Cornell CJ; Forcier RJ; Harrower HW; Johnson RO
    Cancer; 1979 Aug; 44(2):732-41. PubMed ID: 383261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet aggregation inhibitors and metastatic spread of neoplastic cells.
    Ambrus JL; Ambrus CM; Gastpar H
    Prog Clin Biol Res; 1982; 89():83-95. PubMed ID: 7111311
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate. Final report of VA Cooperative Study #75.
    Zacharski LR; Henderson WG; Rickles FR; Forman WB; Cornell CJ; Forcier RJ; Edwards RL; Headley E; Kim SH; O'Donnell JF
    Cancer; 1984 May; 53(10):2046-52. PubMed ID: 6322957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mopidamol in non-small cell lung cancer: anti-oncogene or accident?
    Livingston RB
    J Natl Cancer Inst; 1988 Mar; 80(2):77-8. PubMed ID: 2830406
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimetastatic and antitumor effect of platelet aggregation inhibitors.
    Ambrus JL; Ambrus CM; Gastpar H; Huberman E; Montagna R; Biddle W; Leong S; Horoszewicz J
    Prog Clin Biol Res; 1982; 89():97-111. PubMed ID: 7111312
    [No Abstract]   [Full Text] [Related]  

  • 9. Mopidamol.
    J Natl Cancer Inst; 1988 Jun; 80(7):532-4. PubMed ID: 2835491
    [No Abstract]   [Full Text] [Related]  

  • 10. Drugs effect on platelet survival time: comparison of two pyrimido-pyrimidine derivatives in patients with aortic or mitral replacement.
    Schbath J; Boissel JP; Mathy B; Ville D; Benveniste E; Sanchini B; Leizorovicz A; Belleville J; Dechavanne M; Maitre P
    Thromb Haemost; 1984 Feb; 51(1):45-9. PubMed ID: 6719387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small cell carcinoma of the lung: interaction with the blood coagulation mechanism and treatment with anticoagulants.
    Zacharski LR
    Onkologie; 1987 Aug; 10(4):264-70. PubMed ID: 2823201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets and platelet-inhibitor drugs in aortocoronary vein bypass operations.
    Chesebro JH; Fuster V
    Int J Cardiol; 1983; 2(5-6):511-6. PubMed ID: 6341260
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet pyrimido-pyrimidines and metastasis.
    Lichtner RB; Hutchinson G; Wedderburn N; Hellmann K
    Cancer Treat Rev; 1985 Dec; 12(4):221-34. PubMed ID: 3009013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor interaction with hemostasis: the rationale for the use of platelet inhibitors and anticoagulants in the treatment of cancer.
    Al-Mondhiry H
    Am J Hematol; 1984 Feb; 16(2):193-202. PubMed ID: 6364802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of 2,6-bis(diethanolamino)-4-piperidinopyrimido [5,4-d]-pyrimidine (RA233) on growth, metastases and lung colony formation of B16 melanoma.
    Maniglia CA; Tudor G; Gomez J; Sartorelli AC
    Cancer Lett; 1982 Sep; 16(3):253-60. PubMed ID: 7151045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant therapy of non-small cell bronchial cancer with mopidamol].
    Blaha H; Dierkesmann R; Feuerer W; Gatzemaier U; Geser C; Lemme J; Mall W; Ritscher R; Schneider B; Vallee D
    Pneumologie; 1989 Jun; 43(6):299-304. PubMed ID: 2547216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood platelets and tumour dissemination.
    Hilgard P
    Prog Clin Biol Res; 1982; 89():143-58. PubMed ID: 7111296
    [No Abstract]   [Full Text] [Related]  

  • 18. Inhibitory action of flurbiprofen and mopidamole on tumor lung metastasis formation in mice.
    Mamytbeková A; Rezábek K; Grimová J; Svobodová J
    Cancer Treat Rep; 1987 Nov; 71(11):1089-90. PubMed ID: 3677114
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of vitamin K-antagonists on survival of patients with malignancy: a systematic analysis.
    Smorenburg SM; Vink R; Otten HM; Swaneveld F; Büller HR
    Thromb Haemost; 2001 Dec; 86(6):1586-7. PubMed ID: 11776335
    [No Abstract]   [Full Text] [Related]  

  • 20. Placebo-controlled study on the efficacy of the pyrimido-pyrimidine derivative RA 233 in ovarian cancer.
    Nieminen U; Kauppila A; Grönroos M; Kuoppala T; Väyrynen M
    Gynecol Oncol; 1990 Feb; 36(2):226-31. PubMed ID: 2404838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.